Magnesium Sulfate CRI
Refractory ventricular arrhythmias (VPCs, ventricular tachycardia, torsades de pointes) in dogs and cats, particularly when hypomagnesemia is documented or suspected. Generally chosen after standard antiarrhythmic options (lidocaine for VT, procainamide) have not produced adequate control. Also used for severe documented hypomagnesemia replacement (CRI preferred over bolus for severe deficiency). Adjunct for refractory bronchospasm in severe asthma is described but less common in veterinary practice. Continuous ECG and BP monitoring required.
How this calculator works
Enter the patient's weight and the desired CRI dose. The calculator picks a concentration (100, 50, or 25 mg/mL) that keeps the pump in its accurate range (≥ 2 mL/hr for most syringe pumps).
The recommended concentration shows a suggested tag that updates as you change the patient inputs. Click any tab to override.
Loading dose for ventricular arrhythmia (25–50 mg/kg IV over 5–10 min) is shown above the CRI maintenance rate. Slow administration minimizes the hypotension risk.
Enter a patient weight to see the result.
How the calculation works
Magnesium Sulfate CRI is dosed in mg/kg/hr. Because the prepared CRI concentration is expressed in µg/mL, the formula needs a × 1000 to convert the mg dose into µg before dividing:
Patient weight (kg) times dose (mg per kg per hour) gives mg per hour. Multiplying by 1,000 converts mg to µg so the units match the bag concentration. Dividing by µg/mL yields mL per hour.
Worked example with current inputs
Enter a patient weight to see the worked example.
Recommended dilutions
| Target concentration | Dilution | When useful |
|---|---|---|
| 100000 µg/mL | 10 mL of 50% stock (5 000 mg total) into 40 mL of 0.9% NaCl or 5% dextrose, final volume 50 mL | Concentrated preparation for patients ≥10 kg. Most common ICU prep for medium-to-large dogs at the typical 25 mg/kg/hr dose. |
| 50000 µg/mL | 5 mL of 50% stock (2 500 mg total) into 45 mL of 0.9% NaCl or 5% dextrose, final volume 50 mL | Standard preparation for patients 3–10 kg. The textbook 1:10 dilution of the 50% stock. |
| 25000 µg/mL | 2.5 mL of 50% stock (1 250 mg total) into 47.5 mL of 0.9% NaCl or 5% dextrose, final volume 50 mL | Dilute preparation for patients <3 kg or any patient at very low doses where the 50 mg/mL preparation would drop pump rate below 2 mL/hr. |
Standard preparation: dilute the 50% magnesium sulfate stock (500 mg/mL) into a 50 mL syringe with 0.9% NaCl or 5% dextrose. Both diluents are compatible. For longer-running infusions, the same concentrations can be prepared in 100 mL or 250 mL bags using proportionally more stock. Compatibility caveats: magnesium sulfate is incompatible with many calcium-containing solutions (precipitation risk) and with sodium bicarbonate. Do not co-administer in the same line with these; flush the line before and after if a Y-site is unavoidable. Monitoring: serum magnesium 4–6 hours after starting the CRI where available, then every 12–24 hours. Patellar reflex check as an objective hypermagnesemia surveillance test; loss of patellar reflex is the earliest sign and prompts immediate dose reduction or hold.
Dilution helper — Magnesium Sulfate CRI
Work out how many mL of stock drug and diluent to combine for any target concentration. Stock is pre-filled for Magnesium Sulfate CRI; change it if you're using a different vial.
Enter stock, target concentration, and final volume.